Fig-1 (Lansoprazole Figure 1)
Lansoprazole Capsule, Delayed Release
Product Images NDC 33342-310
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 33342-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig-2 (Lansoprazole Figure 2)
Lansoprazole-structure (Lansoprazole Structure)
546 (Lansoprazole Tablets 15 mg 30s)
This is a description for Lansoprazole Delayed-Release Capsules, USP containing 15 mg of the active ingredient lansoprazole. Each capsule is printed with "C86" and "15 mg" for identification. The medication guide for patients is available at www.macleodspharma.com/usa. The capsules are opaque pink and opaque green with enteric-coated granules. The usual dosage information is provided in the package insert. The product should be stored at temperatures between 20°C to 25°C (68°F to 77°F). It is important not to use the product if the seal over the bottle opening is broken or missing. Made by Macleods Pharma USA, Inc., the product comes in a packaging of 30 capsules with a National Drug Code (NDC) of 33342-310-07. Keep the capsules in a tight container and out of reach of children. Made in India.*
657 (Lansoprazole Tablets 30 mg 30s)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
